Eyes on Pfizer

Pfizer has agreed to pay Washington University in St. Louis $22.5 million to take another look at more than 500 drugs and failed drug candidates to see whether the university's researchers can find new uses for them, report the Wall Street Journal .

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Oxford Nanopore Technologies is looking into dual listings in London and Hong Kong, according to the South China Morning Post.

The New York Times looks into medical research funding in the US and how the grant system might not be funding the best work.

US lawmakers proposed increasing the National Science Foundation budget, including its facilities account, Science reports.

In PNAS this week: effects of gene deletions on bacterial metabolic networks, genetic responses to sea star wasting disease, and more.